These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 2695437

  • 21. [Fully implantable catheter systems for arterial extremity infusion].
    Krawzak HW, Strosche H.
    Chirurg; 1989 Jul; 60(7):475-8. PubMed ID: 2791734
    [Abstract] [Full Text] [Related]

  • 22. [Ifenprodil tartrate in the treatment of occlusive arteriopathies of the lower limbs. Results of a prospective double-blind controlled multicenter trial].
    Natali J, Kieny R, Le Bas P, Benhamou M, Molkhou JM.
    Ann Cardiol Angeiol (Paris); 1989 Jun; 38(6):339-42. PubMed ID: 2667444
    [No Abstract] [Full Text] [Related]

  • 23. [The clinico-instrumental evaluation of the efficacy of picotamide in treating chronic obstructive arteriopathies of the lower extremities].
    Canonico V, Ammaturo V, Guarini P, Tedeschi C, Nunziata G, Nappi A, Forgione L, Rengo F.
    Minerva Cardioangiol; 1991 Mar; 39(3):75-80. PubMed ID: 1881558
    [Abstract] [Full Text] [Related]

  • 24. [Intravenous pentoxifylline in Fontaine stage II and III peripheral arterial diseases].
    Giansante C, Di Chiara A, Fiotti N, Mauri F, Sorrentino A, Spanghero M, Tomasin L, Calabrese S.
    Clin Ter; 1990 Sep 15; 134(5):301-5. PubMed ID: 2149312
    [Abstract] [Full Text] [Related]

  • 25. The long-term tolerability of bencyclane ('Fludilat') in patients with peripheral occlusive disease: a 48-week prospective double-blind controlled study versus placebo.
    Herrmann WM, Schärer E.
    Curr Med Res Opin; 1991 Sep 15; 12(6):356-65. PubMed ID: 2044395
    [Abstract] [Full Text] [Related]

  • 26. [New data on vasoactive drug. Patients with peripheral arterial occlusive disease walk twice as long].
    MMW Fortschr Med; 2002 May 23; 144(21):54. PubMed ID: 12134429
    [No Abstract] [Full Text] [Related]

  • 27. [Buflomedil chlorhydrate in peripheral vasculopathies].
    Dall'Antonia F, Perbellini A, Adami CA, Dal Cortivo G, Bucci S.
    Clin Ter; 1986 Dec 15; 119(5):379-85. PubMed ID: 2951055
    [No Abstract] [Full Text] [Related]

  • 28. [Oral trapidil treatment of Fontaine stage II arteriosclerotic circulatory disorders of the legs--a double-blind study].
    Voigt H, Reuter W, Hofmann B, Dobberkau A.
    Z Gesamte Inn Med; 1990 May 15; 45(10):283-7. PubMed ID: 2392858
    [Abstract] [Full Text] [Related]

  • 29. [Treatment of disorders of cerebral performance in the aged in ambulatory care using bencyclane. Results of a controlled double-blind phase III study versus placebo].
    Garweg G, Herrmann WM, Kern U.
    Z Gerontol; 1987 May 15; 20(1):56-62. PubMed ID: 3554804
    [Abstract] [Full Text] [Related]

  • 30. Comparison between intravenous iloprost and vasoactive drugs in limb ischemia IIB severe. A retrospective analysis.
    Di Salvo MM, Ardita G, Giani L, Mugno F, Stevenazzi F, Mazzone A.
    Minerva Cardioangiol; 2006 Jun 15; 54(3):377-81. PubMed ID: 16733512
    [Abstract] [Full Text] [Related]

  • 31. [Prostacyclin and pentoxifylline in the treatment of patients with inoperable occlusions of the peripheral arteries of the lower extremities].
    Maksimović ZV.
    Srp Arh Celok Lek; 1999 Jun 15; 127(7-8):249-53. PubMed ID: 10624398
    [Abstract] [Full Text] [Related]

  • 32. [Intravenous and intra-arterial prostaglandin E1 treatment in patients with stage IIb arterial occlusive disease].
    Rudofsky G.
    Vasa Suppl; 1988 Jun 15; 23():121-5. PubMed ID: 3206330
    [No Abstract] [Full Text] [Related]

  • 33. [Action of Buflomedil on the cutaneous microcirculation studies by a cold provocation test. Multicenter, double-blind, placebo controlled trial].
    Maurel A, Betrancourt JC, Van Frenkel R, Thuillez C.
    J Mal Vasc; 1995 Jun 15; 20(2):127-33. PubMed ID: 7650439
    [Abstract] [Full Text] [Related]

  • 34. [MR-Imaging of lower leg muscle perfusion].
    Leppek R, Hoos O, Sattler A, Kohle S, Azzam S, Al Haffar I, Keil B, Ricken P, Klose KJ, Alfke H.
    Herz; 2004 Feb 15; 29(1):32-46. PubMed ID: 14968340
    [Abstract] [Full Text] [Related]

  • 35. [Therapeutic use of flunarizine in the treatment arteriopathies of the lower extremities].
    Ambrosi V, Gabrielli F.
    Minerva Med; 1983 Mar 31; 74(13):685-9. PubMed ID: 6220230
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [Vasodilative effect of halidor administered at different periods to patients with glaucoma].
    Osobenko NS.
    Vestn Oftalmol; 1980 Mar 31; (1):6-9. PubMed ID: 7368478
    [No Abstract] [Full Text] [Related]

  • 38. [Conservative therapy of arterial occlusive diseases. Double-blind study on the effect of butalamine hydrochloride].
    Seboldt H.
    Fortschr Med; 1980 Feb 21; 98(7):257-60. PubMed ID: 6767648
    [Abstract] [Full Text] [Related]

  • 39. Oral buflomedil in the prevention of cardiovascular events in patients with peripheral arterial obstructive disease: a randomized, placebo-controlled, 4-year study.
    Limbs International Medicinal Buflomedil (LIMB) Study Group, Leizorovicz A, Becker F.
    Circulation; 2008 Feb 12; 117(6):816-22. PubMed ID: 18212283
    [Abstract] [Full Text] [Related]

  • 40. LYS-plasminogen shortens the duration of local thrombolytic treatment of peripheral arterial occlusions--a randomized controlled trial.
    Poredos P, Videcnik V.
    Wien Klin Wochenschr; 1999 Jan 15; 111(1):21-5. PubMed ID: 10067266
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.